C4 Therapeutics, Inc.

Rachunek Zysków i Strat





index 0 1 2 3 4 5 6
Rok finansowy 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 19 21 33 46 31 21 36
Przychód Δ r/r 0.0% 10.4% 55.3% 37.9% -32.1% -33.3% 71.4%
Marża brutto 100.0% -122.9% -133.4% 93.7% 75.6% 62.7% 100.0%
EBIT (mln) -16 -35 -60 -82 -130 -139 -120
EBIT Δ r/r 0.0% 116.3% 70.5% 35.9% 57.7% 7.3% -14.0%
EBIT (%) -84.6% -165.8% -182.1% -179.4% -416.6% -669.8% -336.1%
Koszty finansowe (mln) 0 0 1 2 2 1 0
EBITDA (mln) -15 -34 -58 -80 -126 -131 -103
EBITDA(%) -78.1% -158.4% -176.0% -175.3% -405.1% -632.6% -290.5%
Podatek (mln) 1 1 -1 2 -2 1 0
Zysk Netto (mln) -16 -34 -66 -86 -126 -132 -105
Zysk netto Δ r/r 0.0% 117.0% 94.5% 29.7% 47.0% 4.7% -20.5%
Zysk netto (%) -81.1% -159.5% -199.8% -187.9% -406.8% -638.3% -296.0%
EPS -1.06 -0.79 -1.54 -1.87 -2.59 -2.67 -1.52
EPS (rozwodnione) -1.06 -0.79 -1.54 -1.87 -2.59 -2.67 -1.52
Ilośc akcji (mln) 15 43 43 46 49 50 69
Ważona ilośc akcji (mln) 15 43 43 46 49 50 69
Waluta USD USD USD USD USD USD USD